Carrie D'Andrea
Chief Tech/Sci/R&D Officer at ACASTI PHARMA INC.
Net worth: - $ as of 2024-03-30
Carrie D'Andrea active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ACASTI PHARMA INC. | Chief Tech/Sci/R&D Officer | 2023-05-07 | - |
Career history of Carrie D'Andrea
Former positions of Carrie D'Andrea
| Companies | Position | Start | End |
|---|---|---|---|
EryDel SpA
 EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Corporate Officer/Principal | 2020-09-30 | 2021-03-31 |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Chief Tech/Sci/R&D Officer | 2014-09-30 | 2019-02-28 |
Training of Carrie D'Andrea
| Temple University (Pennsylvania) | Graduate Degree |
Statistics
International
| United States | 4 |
| Italy | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Graduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ACASTI PHARMA INC. | Health Technology |
| Private companies | 2 |
|---|---|
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Health Technology |
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Health Technology |
- Stock Market
- Insiders
- Carrie D'Andrea
- Experience